Article

Development of a MET-targeted single-chain antibody fragment as an anti-oncogene targeted therapy for breast cancer

2022-11-02

Abstract excerpt

The usage of monoclonal antibodies (mAbs), as a matter associated with the biopharmaceutical industry, is increasingly growing. Harmonious with this concept, we designed the exquisitely modeled anti-MET scFv against breast cancer by gene cloning, and expression using a bacterial host. Herein, we developed a recombinant scFv against MET and examined its preclinical efficacy for the reduction of tumor growth, invasi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 38a77ac8-8983-5116-91a7-30cf1f6082da
DOI: 10.21203/rs.3.rs-2216162/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Development of a MET-targeted single-chain antibody fragment as an anti-oncogene targeted therapy for breast cancerDOI 10.21203/rs.3.rs-2216162/v1Read

Novel antibody cocktail therapy targeting extracellular tumor-specific mutations to treat triple-negative breast cancerSemantic proximity Read

Generation of a stable anti-human CD44v6 scFv and analysis of its cancer-targeting ability in vitroSemantic proximity Read

Isolation and characterization of a novel human scFv inhibiting EGFR vIII expressing cancers.Semantic proximity Read

Novel antibody cocktail therapy targeting extracellular tumor-specific mutations to treat EMT6 cell line-derived triple-negative breast cancer.Semantic proximity Read

Mammalian cell display for rapid screening scFv antibody therapySemantic proximity Read

A Biparatopic Antibody-Drug Conjugate to Treat MET-Expressing Cancers, Including Those that Are Unresponsive to MET Pathway Blockade.Semantic proximity Read

Development and Evaluation of an Optimal Human Single-Chain Variable Fragment-Derived BCMA-Targeted CAR T Cell VectorSemantic proximity Read

Construction of humanized anti-HER2 single-chain variable fragments (husFvs) and achievement of potent tumor suppression with the reconstituted husFv-Fdt-tBid immunoapoptotin.Semantic proximity Read

Development of an Engineered Single-Domain Antibody for Targeting MET in Non-Small Cell Lung CancerSemantic proximity Read

A new scfv-based recombinant immunotoxin against EPHA2-overexpressing breast cancer cells; High in vitro anti-cancer potency.Semantic proximity Read

Immunotherapeutic Potential of Anti-Human Endogenous Retrovirus-K Envelope Protein Antibodies in Targeting Breast TumorsSemantic proximity Read

Methylsulfonylmethane Suppresses Breast Cancer Growth by Down-Regulating STAT3 and STAT5b PathwaysSemantic proximity Read